FDA Issues Urgent Recall of Chantix Over Cancer-Linked Chemical Concerns
Millions of Americans rely on Chantix, a popular prescription medication designed to help people quit smoking. But the U.S. Food and Drug Administration (FDA) has now issued a nationwide voluntary recall after discovering that certain batches contain elevated levels of
nitrosamines—chemical compounds known to be potentially carcinogenic with long-term exposure.
